Image: Overview: The Dynabeads™ Streptavidin for In Vitro Transcription and Dynabeads Carboxylic Acid for RNA Purification solutions support scalable GMP-grade synthesis and purification of mRNA for vaccine development and manufacturing. The fit-for-purpose solutions, combined with Thermo Scientific™ TheraPure™ GMP* […]
Speakers will discuss how genomics drives more informed, inclusive, and proactive care SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will convene a panel titled “Clinical Genomics Is Now. Are You Ready?” at its inaugural Illumina Genomics Forum (IGF), moderated by Nobel laureate and […]
BioXp™ 9600 system – a fully automated, high-throughput benchtop instrument for synthetic biology workflows – empowers scientists to accelerate discovery of new vaccines and biologics SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the BioXp™ 9600 system, a next-generation […]
New assays for Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6) expand menu to now 16 available CE-IVD assays Improved multiple-target assay for respiratory diseases in development; new dual-target SARS-CoV-2 design enables faster clinical decisions Multiplex assay for detection of monkeypox planned to be made available in 2022 HILDEN, Germany & GERMANTOWN, Md. — QIAGEN […]
Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN’s NGS testing portfolio for precision medicine beyond oncology into neurology applications HILDEN, Germany & GERMANTOWN Md. & SOUTH SAN FRANCISCO, Calif. — QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and Neuron23 Inc., an early stage […]
Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it has invested in six genomics startups for the fifth global funding cycle of […]
Highly customizable synthetic guide RNA (gRNA) libraries, coupled with established CRISPR expertise and support, enables researchers to quickly screen for new drug candidates CORALVILLE, Iowa — Bolstering its commitment to providing researchers with powerful tools to discover more about biology and advance medicine, global genomics solutions provider Integrated DNA Technologies (IDT) is expanding access to its customization […]
Dr. Sam Globus Joins Executive Team to Lead Scientific Team Curating the Human Genome ANN ARBOR, MICH. — Genomenon, Inc., an AI-driven genomics company, announced today that Dr. Sam Globus has been appointed vice president of operations. To support Genomenon’s goal to curate the entire human genome, Globus will manage the rapid growth of the […]
TriLink now offers GMP-grade N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allowing researchers to accelerate their drug discovery and development timelines and US-source their supply chain SAN DIEGO — TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and global provider of life science reagents and services, has expanded its GMP-grade product offering to […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG), a leader in food and animal safety, announced today that it has appointed two new members to its Board of Directors: Jeffrey Capello and Aashima Gupta. The addition of Mr. Capello and Ms. Gupta was agreed by Neogen and 3M Company under the merger agreement for the 3M Food Safety […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
